Key Segmentation
By Product Type
-
Dried Blood Spot (DBS) Cards
-
FTA (Flinders Technology Associates) Cards
-
Guthrie Cards (Neonatal Screening Cards)
-
Protein Saver Cards
-
Others
By Application
-
Newborn Screening
-
Infectious Disease Testing
-
Forensic & DNA Analysis
-
Therapeutic Drug Monitoring
-
Others
By End User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Research & Academic Institutes
-
Forensic Laboratories
-
Blood Banks
By Sample Type
-
Blood Samples
-
Saliva Samples
-
Buccal Swabs
-
Other Biological Samples
By Distribution Channel
-
Direct Sales
-
Distributors & Suppliers
-
Online Channels
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated with a 35.84% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 6.63% during 2026–2035.
Ans: Dried Blood Spot (DBS) Cards dominated with a 46.25% share in 2025, while Protein Saver Cards are projected to grow at the fastest CAGR of 7.06% during 2026–2035.
Ans: Growth is driven by rising adoption of decentralized diagnostics and newborn screening programs, along with increasing demand for cost-effective, stable, and easy-to-transport biological sample collection solutions.
Ans: The market is valued at USD 481.32 Million in 2025 and is projected to reach USD 805.41 Million by 2035.
Ans: The Specimen Collection Cards Market is projected to grow at a CAGR of 5.37% during 2026–2035.